Market Overview

UPDATE: Morgan Stanley Reiterates On PHH On Revised Operating Estimates

Related PHH
Benzinga's Top Upgrades
PHH Corp's Long Runway To Regaining Profitability Keeps Morgan Stanley On The Sidelines, Says Stock Reaction To Regulatory Upside Is Likely Overdone
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q3 2015 Update (Seeking Alpha)

In a report published Thursday, Morgan Stanley analyst Cheryl M. Pate reiterated an Equal-Weight rating on PHH (NYSE: PHH), and raised the price target from $24.00 to $26.00.

In the report, Morgan Stanley noted, “Following the completed Fleet sale, we revise our operating estimates higher on (1) a more aggressive pace of capital return from greater than expected buybacks, and (2) clarity on the path to enhance profitability in the mortgage business. While execution remains a risk and profitability levels in mortgage are likely to remain challenged in the near-term, we are increasing our price target by $2 to $26 given capital leverage from higher buybacks as well as increased comfort with PHH's move to re-orient the business. We expect the stock will re-rate higher over time as PHH executes on improving profitability, but normalized earnings are 2-3 years out.”

PHH closed on Wednesday at $22.67.

Latest Ratings for PHH

Aug 2015Keefe Bruyette & WoodsUpgradesMarket PerformOutperform
Aug 2015FBR CapitalDowngradesOutperformMarket Perform
May 2015Keefe Bruyette & WoodsMaintainsMarket Perform

View More Analyst Ratings for PHH
View the Latest Analyst Ratings

Posted-In: Cheryl M. Pate Morgan StanleyAnalyst Color Price Target Analyst Ratings


Related Articles (PHH)

View Comments and Join the Discussion!

Get Benzinga's Newsletters